In addition, felodipine treatment decreased NLRP3 mRNA levels in the cortex and hippocampus region of Tau Tg PS19 mice (Fig. 1E), suggesting that felodipine treatment may downregulate tauopathy-associated neuroinflammatory responses by inhibiting NLRP3 expression. This evidence concerns the gene NLRP3 and tauopathy.